Irccs Istituto Ortopedico Rizzoli
Bologna, Emilia-Romagna, 40136, Italy
Location status: Recruiting
Location contact
Marcella Lanza, PhD
CONTACT
Marina Mordenti, PhD
CONTACT
NCT Number: NCT04134572
REM is a retrospective and prospective registry, finalized to care and research. It is articulated in main sections - strongly related and mutually dependent on each other - corresponding to different data domains: personal information, clinical data, genetic data, genealogical data, surgeries, etc..
This approach has been individuated in order to corroborate and integrate data from different resources and aspects of the diseases and to correlate genetic background and phenotypic outcomes, in order to better investigate diseases pathophysiology. Due to legal requirements, institutional directives and organizational issues, we are unable to include individuals residing outside Italy in the registry at this time. We are currently engaged in the preparation of a recruitment process for individuals residing outside Italy.
Interested in participating?
Request InfoAll sexes
Observational
Bologna, Emilia-Romagna, 40136, Italy
Location status: Recruiting
Marcella Lanza, PhD
CONTACT
Marina Mordenti, PhD
CONTACT
The traditional method of collecting patient information is often chaotic, inconvenient and sometimes even unsafe, particularly when dealing with rare diseases. In 2017, the need to simplify the diagnostic process and to overcome the difficulties of data storage and analysis, led to the suggestion of implementing the Registry of Ollier Disease and Maffucci Syndrome (ROM).
The ROM relies on an IT platform named Genotype-phenotype Data Integration platform - GeDI. This solution, realized by a collaboration among Medical Genetic Department and a local software-house (Dilaxia Spa), is a General Data Protection Regulation (GDPR)-compliant, multi-client, web-accessible system and it has been designed according to current medical informatics standards (Orphanet code, ICD-10, Human Genome Variants Society, Findability Accessibility Interoperability Reusability Principles). GeDI is continuously implemented to improve management of persons with Ollier Disease and Maffucci Syndrome and to help researchers in analyzing collected information. ROM is articulated in main sections:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 25 years
To maintain an established registry in order to assess epidemiology and natural history.
Collection of:
Clinical, orthopedic, surgical, treatment and functional features are updated at each follow up. Clinical reports, medical charts and imaging are the primary sources of data.
Time frame: 25 years
Despite the unclear genetic background of Ollier disease and Maffucci syndrome, the secondary outcome aims to correlate genotype and phenotype. This includes, but is not limited to clinical features and genetic background. This will be pursued using the information collected during visits and follow-ups.
Time frame: 25 years
This outcome aims to investigate the evolution of Ollier Disease and Maffucci Syndrome during time.
Main clinical features such as height (cm), number and localization of enchondromas, number and localization of deformities, number and localization of limitations, site/age at malignant transformation will be collected both retrospectively and prospectively in the entire population.
Those data will be collected both retrospectively and prospectively for all patients via physical examination, clinical reports and imaging.
An evaluation of these parameters will be performed at each visit to keep track on the progression of the clinical manifestations. Data will be collected to define annualized rate of new clinical manifestations related to age, using analyses such as Kaplan-Meyer and surviving rate.
Contact information is provided by the study sponsor or research team.
Marcella Lanza, PhD
CONTACT
Marina Mordenti, PhD
CONTACT
Luca Sangiorgi
Other
Registry of Ollier Disease and Maffucci Syndrome That Collects Clinical, Functional, Genetic, Genealogical, Imaging, Surgical, Treatment, Quality of Life Data. Data is Linked to Patients' Biological Samples, When Available
Acronym: ROM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04844697
Bone Diseases, Bone Diseases, Developmental
Bologna, Italy
View Trial DetailsNCT06397443
Behavior, Bone Diseases
Bologna, Italy
View Trial DetailsNCT06749366
Bone Diseases, Bone Diseases, Developmental
Bethesda, Maryland, United States
View Trial DetailsNCT07379008
Bone Cysts, Bone Defects
Gdansk, Pomeranian Voivodeship, Poland
View Trial Details